{"name":"GeneQuantum Healthcare (Suzhou) Co., Ltd.","slug":"genequantum-healthcare-suzhou-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dose Expansion1","genericName":"Dose Expansion1","slug":"dose-expansion1","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Dose Expansion1","genericName":"Dose Expansion1","slug":"dose-expansion1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQc0E0M18xMXVnOHI0bXVfb05OYnZMN3B2RjlwWHBUdjFlNWJXbWNjSjNNMjFyMnhrNlBnbkFFcTFDR3Z5MlIwZ0ZZXzE0bk9haWNSX09iNzhLRW0zdzlDTDJjRTFHSWlub01nUVI5ZmtJSFdzcTRWT0lsRUcyQV9IMWZqbWxBRG1kWGlBaHJFajZMeC1CRTBfLUxiWFhOYnJDUHVFNTM2UURaOVM2U0ZsMFB2MkpHR0tuZlZ2ejc5S2tMU3A1NGcxUHBLdw?oc=5","date":"2026-01-14","type":"deal","source":"Caixin Global","summary":"Chinese Drugmakers Strike Record $136 Billion in Cross-Border Licensing Deals - Caixin Global","headline":"Chinese Drugmakers Strike Record $136 Billion in Cross-Border Licensing Deals","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-08","type":"deal","source":"South China Morning Post","summary":"Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025 - South China Morning Post","headline":"Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTXFVWVhIV2w2UVBFZXBVT1pkQjZKYXk4THlHZmtNNFZUbDNnWkNwVURUb1pYVGJ2b3owcXBBb3lFczNlMjNtbDV3WjRxWGtfT1hkRWkyYkRxX0M5Sk1RVUlIX1dWRUxscV9ybTRuTkxvVFc4THB0cXNqRHNKZDQzd2p0eG1pamlRX1lWNG1VT3ZQSVhVek5tUjNtZlZZX2RFeGVpM1VyaEVnNmhiNXBTd21RYmVENm84?oc=5","date":"2025-11-13","type":"regulatory","source":"BioPharma APAC","summary":"GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia - BioPharma APAC","headline":"GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFB2NTZVTE1kOXcwTjRVODlaMjE5Z2tEakgyenRmdXIzM1ladGdHdzM4c3k3SEZ6ZXF1WjdrRkhjbHQwVnpyOUU2WVNPWXRXRTRDSkdhWjdnSWtHeTBSTV9scnhIX1p4RlV0LWczdDF5LWhCNXpwX3VDRA?oc=5","date":"2025-05-23","type":"deal","source":"Law.asia","summary":"Han Kun advises 3SBio in landmark Pfizer licensing deal - Law.asia","headline":"Han Kun advises 3SBio in landmark Pfizer licensing deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxNWTRreGdjblpXWTY0OFE4aWtKQ2R4a0N1TzJtZ2RsZFV5UmFhb3ZUR0tGQm5jdEFwUm9KQ3ZHZV9SRTZfOTBKTHJBMmZ2S0sxWURVNDAzS0JnSkJveDhpeTcycXFnY25pMXJ1YVEyYkJINkV0T216WlBORkJoRl9aM19JNDl1NnZEbm5NLUhZSUxYd3hmME1MVEFRckxVd1BHdmlINERQOFg2Vy1IMG94ejFyeFFxLWtRTHJHSU8xU0I1X0pFVzBxQmFLTDRJVXk1M2xKODJ2akRabExnQXhiLWRCbGx3c1owWmN1ZGVoSWF4Qy1uQmJ6ZDR6TW9GZDR2dWtaa0lCTVRzNjZ0OEhjMmE2SHNVR1ZyUTNrNGhDZEw0SnJpWnZzaTNYWV96UEVuVGc4b1VNOFJiTk5mN0FSYmdUZDcyX25HYk84WmU1WmI?oc=5","date":"2025-02-20","type":"pipeline","source":"GlobeNewswire","summary":"Antibody-Drug Conjugates Market to Witness Rapid Growth - GlobeNewswire","headline":"Antibody-Drug Conjugates Market to Witness Rapid Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPZkNON0dSOUxiMUExazhPQWtOV1U5MmdIMDhFN0RxN3dZSTFLZVRKRmt2LTlESTEzYm5OZWdQa2ZzNnVTWnNfTlFGV3ctV2FtZjNpUVBrTkVudjBOaXUtYzhHMDN0UUEtNUhlOTlqenZOWFBwSkZ6TlVIYWFpTjlqQXpUdjRKRk85dl9YWVFn?oc=5","date":"2025-01-31","type":"trial","source":"globaldata.com","summary":"Antibody-Drug Conjugates – Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals - globaldata.com","headline":"Antibody-Drug Conjugates – Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNQjlxc3JUM0xPVHBNY2pyam5fV3pnNk80MW9lSmFkV1kyOGtzRFpNbkZmTy1fMmM1Y0EzZXlHOHl4OWZtMFJfc1l0WHFtbWNjYzVrUDlWSDFkTE9pbi13Tm9wQk00dmtXeVpEWnc4X2k3T3hPZEpVemdGNjJtcDFnU0EzcnRCUFoySDY4VXh5cks4T0tBeU1uNm54RXlNS3lWRmlheUNvbnZMZUpabU5lQ24ySmlyOXZoMi1ZRXJ3UFRoZzA2MXJFbzRDV000dmxoeTE5QnRoMm90Z1NIZmZGZVZkUWFJRkpoWGFBbDJDUGxPRWxOelowdjZoazlaWlpXcldrMkpLWkxZRVRaUTJ0RURwaUtWbE9odDEyOHhtRDlFdw?oc=5","date":"2024-05-29","type":"pipeline","source":"PR Newswire","summary":"Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PR Newswire","headline":"Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNckRueUZLMVBOM0U2bERPQ19VdENVVVVVby1VR1VFR2V1c3FKM0tLbzhLYmxJNFVoMmJIZ2VUXzhpQ1ZIVlhmSGVVRzBwMTFndWFsemNiRmZuS0JBc2ZrNUFlbXNSRnIyaEFPQUtfNy03OUdnV1FwczNZODI2bzBjSjRmdzZrZHl5TWwySGMwTkRNeHdKYzFnX0p4ZFpMMHZ6bXJRSi1pZFFwc3M?oc=5","date":"2017-03-27","type":"pipeline","source":"PR Newswire","summary":"GeneQuantum Closes RMB40 Million Series A Financing - PR Newswire","headline":"GeneQuantum Closes RMB40 Million Series A Financing","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}